Dr. David Zagzag serves New York University Langone Medical Center as a professor of neurosurgery and the director of the Human Brain Tumor Bank. Over his career, Dr. David Zagzag has earned numerous honors, including the Pioneer Award from the Children’s Brain Tumor Foundation and the Lucien J. Rubenstein Award for Best Paper on Neuro-Oncology.

1. Dr. David Zagzag

2.  Dr. David Zagzag serves New York University Langone
Medical Center as a professor of neurosurgery and the
director of the Human Brain Tumor Bank. Over his career, Dr.
David Zagzag has earned numerous honors, including the
Pioneer Award from the Children’s Brain Tumor Foundation
and the Lucien J. Rubenstein Award for Best Paper on Neuro-
Oncology.
When doctors use the word “malignant” to describe a brain
tumor, they are referring to a growth that represents a cancer
capable of metastasizing, to other tissue. Interestingly, many
malignant brain cancers do not spread to outside organ
systems, like other cancers are prone to do.

3.  However, benign or non malignant does not
necessarily mean harmless, as benign brain
tumors can put pressure on in the brain, leading to
life-threatening consequences. About a fifth of all
benign brain tumors develop from cells of the
membranes that surround the organ. Other
common sources of benign masses include
Schwann cells and the pituitary gland.
Symptoms of benign tumors often mirror those of
their malignant counterparts. These include
headaches or problems seeing, hearing, and
moving.